These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 7778574

  • 1. Heparin-induced aldosterone suppression and hyperkalemia.
    Oster JR, Singer I, Fishman LM.
    Am J Med; 1995 Jun; 98(6):575-86. PubMed ID: 7778574
    [Abstract] [Full Text] [Related]

  • 2. Heparin-induced hyperkalemia.
    Aull L, Chao H, Coy K.
    DICP; 1990 Mar; 24(3):244-6. PubMed ID: 2180218
    [Abstract] [Full Text] [Related]

  • 3. Fludrocortisone for the treatment of heparin-induced hyperkalemia.
    Sherman DS, Kass CL, Fish DN.
    Ann Pharmacother; 2000 May; 34(5):606-10. PubMed ID: 10852087
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heparin-induced hyperkalemia.
    Edes TE.
    Postgrad Med; 1990 Mar; 87(4):104-6. PubMed ID: 2315239
    [Abstract] [Full Text] [Related]

  • 7. Effects of angiotensin II, adrenocorticotropin, and potassium on aldosterone production in adrenal zona glomerulosa cells from streptozotocin-induced diabetic rats.
    Kigoshi T, Imaizumi N, Azukizawa S, Yamamoto I, Uchida K, Konishi F, Morimoto S.
    Endocrinology; 1986 Jan; 118(1):183-8. PubMed ID: 3000733
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR, Bakris GL, Gross C, Mayo MR, Garza D, Stasiv Y, Yuan J, Berman L, Williams GH.
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heparin-induced hyperkalemia: report of a case.
    Phelps KR, Oh MS, Carroll HJ.
    Nephron; 1980 Sep; 25(5):254-8. PubMed ID: 6247665
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure.
    Zanella MT, Mattei E, Draibe SA, Kater CE, Ajzen H.
    Clin Pharmacol Ther; 1985 Dec; 38(6):613-7. PubMed ID: 2998675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.
    Textor SC, Bravo EL, Fouad FM, Tarazi RC.
    Am J Med; 1982 Nov; 73(5):719-25. PubMed ID: 6291388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.